logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Victor E Marquez

This inventor holds 20 USPTO granted patents, primarily in Nucleoside Analogues. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of, Laboratorios Cosmos S.a.. Active years: 1978-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor E Marquez. Retrieved from https://idiyas.com/inventor/victor-e-marquez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20

% Patents Active = 95.0

Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 151(Granted Patents)


Location History:

  • Caracas, VE (1978 - 1979)
  • Bethesda, MD (US) (1994 - 1998)
  • Gaithersburg, MD (US) (1981 - 1999)
  • Gaithersbury, MD (US) (1999)
  • Santa Fe, NM (US) (2020)

Company Filing History:

goldMedal10 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
silverMedal4 out of 2,202 
 
The United States of America as Represented by the Secretary of
 patents
bronzeMedal2 out of 2 
 
Laboratorios Cosmos S.a.
 patents
4. 1 out of 28 
 
The Government of the United States of America, as Represented by the
 patents
5. 1 out of 28 
 
The United States of America as Represented by the Secretary of Health
 patents
6. 1 out of 1 
 
United States Government as Represented by the Secretary of the Dept. of
 patent
7. 1 out of 834,601 
Other
 patents

Years Active: 1978-2020

Loading Chart...
Areas of Expertise:
Nucleoside Analogues
Antiviral Compounds
Diacylglycerol
Hydantoin
Cyclopentenyl Cytosine
Prodrugs
Phosphoramidite Reagent
Dideoxycytidine
Inhibitors
Chemical Synthesis
2'-Fluorofuranosyl Derivatives
Anaphylactic Inhibitors
20 patents (USPTO):Explore Patents
1. 10588788 - Protective perineal pad (2020-03-17),
2. 5874464 - Conformationally constrained diacylglycerol analogues (1999-02-23),
3. 5869666 - Conformationally locked nucleoside analogues (1999-02-09),
4. 5840728 - Conformationally locked nucleoside analogs as antiherpetic agents (1998-11-24),
5. 5817799 - 2'-Fluorofuranosyl derivatives and methods for preparing (1998-10-06),
6. 5629454 - Conformationally locked nucleoside analogues (1997-05-13),
7. 5565437 - 2',3'-dideoxy-2'-fluoro-purine nucleosides and methods for using same (1996-10-15),
8. 5498719 - Diastereoselective process leading to a key intermediate for the (1996-03-12),
9. 5495010 - Acid stable purine dideoxynucleosides (1996-02-27),
10. 5459256 - Lipophilic, aminohydrolase-activated prodrugs (1995-10-17),
11. 5336764 - 2'-fluorofuranosyl derivatives and novel method of preparing (1994-08-09),
12. 5324831 - Phosphoramidite reagent for chemical synthesis of modified DNA (1994-06-28),
13. 4975434 - Antiviral and anticancer cyclopentenyl cytosine (1990-12-04),
14. 4968690 - 3-deazaneplanocin, intermediates for it, and antiviral composition and (1990-11-06),
15. 4788181 - 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity (1988-11-29),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with information about inventor Victor E Marquez based on the data provided.

Title: Unveiling the Inventive Journey of Victor E Marquez

Introduction:

Victor E Marquez, a prominent inventor in the field of pharmaceutical compositions and nucleoside analogues, hails from Gaithersburg, MD, in the United States. With an impressive portfolio of 19 patents, Marquez has made significant contributions to the realm of biomedical innovation.

Latest Patents:

Marquez's latest patents showcase his expertise in creating impactful solutions in the medical domain:

1. Conformationally Constrained Diacylglycerol Analogues: These analogues, along with pharmaceutical compositions comprising them, serve as potent agonists and antagonists of protein kinase C, a crucial enzyme in cell signaling pathways.

2. Conformationally Locked Nucleoside Analogues: These compounds, including cyclopropane-fused carboxylic nucleoside analogues, hold therapeutic potential as antimetabolites and for developing anti-metabolic agents.

Career Highlights:

Victor E Marquez has been associated with esteemed organizations such as The United States of America As Represented by the Department of Health and The United States of America As Represented by the Secretary of the. His impactful contributions have not only advanced scientific knowledge but also paved the way for potential medical breakthroughs.

Collaborations:

Throughout his career, Marquez has collaborated with accomplished individuals in the field. Notable among them are John S Driscoll and James A Kelley, with whom he has synergized to bring forth innovative solutions in pharmaceutical sciences.

Conclusion:

In conclusion, Victor E Marquez stands as a beacon of innovation in the biomedical landscape, with a track record of pioneering patents that have the potential to reshape the future of pharmaceutical research and development. His dedication to scientific excellence and collaborative spirit exemplify the essence of inventive spirit and transformative impact in the realm of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…